A5069281700- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- Monoclonal and Polyclonal Antibodies Research
- Cancer Immunotherapy and Biomarkers
- Cutaneous lymphoproliferative disorders research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Viral-associated cancers and disorders
- Palliative Care and End-of-Life Issues
- Acute Lymphoblastic Leukemia research
- Quinazolinone synthesis and applications
- RNA modifications and cancer
- Multiple Myeloma Research and Treatments
- Cancer Treatment and Pharmacology
- Patient Dignity and Privacy
- Ovarian cancer diagnosis and treatment
- Economic and Financial Impacts of Cancer
- Tissue Engineering and Regenerative Medicine
- Climate Change and Health Impacts
- Muscle Physiology and Disorders
- PI3K/AKT/mTOR signaling in cancer
- Cancer Mechanisms and Therapy
- Ethics in medical practice
- Peptidase Inhibition and Analysis
- Cancer-related gene regulation
The University of Texas MD Anderson Cancer Center
2015-2023
Summary Lack of consensus for first‐line marginal zone lymphoma ( MZL ) treatment and toxicities associated with currently available systemic therapies have inspired evaluation immunotherapeutic agents yielding robust outcomes improved tolerability. We previously reported durable efficacy lenalidomide rituximab (R 2 in follicular lymphoma, small lymphocytic a subsequent long‐term follow‐up shown here patients. This phase investigator‐initiated study included untreated, stage III / IV...
Novel immunotherapy and biologic agents are being developed with the potential to improve outcomes reduce long-term toxicities among individuals hematologic malignancies. These emerging drugs affect neoplastic cells surrounding microenvironment, causing unique immune-mediated toxicities. .The aim was develop an algorithm for clinical staff manage associated next-generation immunotherapies indicated in population, using a system-focused approach. .Data were collected specific based on four...
7531 Background: Relapsed follicular lymphoma (FL) remains a challenge and salvage regimens are associated with toxicity limited control. Outcomes linked to the immune microenvironment lenalidomide rituximab highly active in FL. Obinutuzumab has increased ADCC compared preclinical models is approved for relapsed We hypothesized that immunologic properties of obinutuzumab would be synergistic. The study objective was determine MTD FL describe efficacy combination. Methods: This open label...
Background To advance oncology nursing science and clinical practice, researchers clinicians must understand the important real-world concerns of nurses who provide direct care to people with cancer or manage processes that support patient care. Objective This study developed a comprehensive compendium among built consensus regarding their importance. Methods Using Delphi survey methodology, this prospective, descriptive was performed in 3 phases: (1) identification experts, defined as...
Introduction: Relapsed follicular lymphoma (FL) remains a challenge and salvage regimens are associated with toxicity limited control. Clinical outcomes linked to dynamic changes in the immune microenvironment novel immune-based approaches such as lenalidomide rituximab highly active both frontline relapsed disease. Obinutuzumab has increased antibody dependent cellular cytotoxicity (ADCC) compared preclinical models is approved for FL. We hypothesized that immunologic properties of...
Objectives: To investigate the ethical challenges experienced by oncology clinical trials nurses (OCTNs) during management of CTs and to examine how they resolve those conflicts. Sample & Setting: 12 licensed RNs who had been practicing as full- or part-time OCTNs for a minimum two years at various academic medical centers in United States. Methods Variables: Classical grounded theory (CGT), an inductive methodology used explore social process which little is known develop data, was used,...
Clinical research nurses and non-licensed study coordinators observed variation in procedures for reconciliation disposal of oral investigational medications across the institution. An academic medical center implemented a quality improvement project to standardize process medications. interprofessional collaborative workgroup was formed, which led multiple interventions practice, including revision three policies procedures, redesign specific work areas establish drug-counting rooms, review...
Earn free contact hours: Click here to connect the evaluation. Certified nurses can claim no more than 1 total ILNA point for this program. Up may be applied Nursing Practice OR Oncology Professional Practice/Performance Roles of APRN. See www.oncc.org complete details on certification.